MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 52 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,730,411 | +28.5% | 118,051 | +5.2% | 0.00% | 0.0% |
Q2 2023 | $2,902,356 | +101.9% | 112,190 | +87.4% | 0.00% | – |
Q1 2023 | $1,437,765 | +12.5% | 59,857 | -8.6% | 0.00% | – |
Q4 2022 | $1,277,485 | +0.0% | 65,512 | +7.8% | 0.00% | – |
Q3 2022 | $1,277,000 | -10.9% | 60,775 | -17.5% | 0.00% | – |
Q2 2022 | $1,433,000 | +178.3% | 73,647 | +215.2% | 0.00% | – |
Q1 2022 | $515,000 | +33.8% | 23,368 | -3.4% | 0.00% | – |
Q4 2021 | $385,000 | -18.9% | 24,194 | +1.5% | 0.00% | – |
Q3 2021 | $475,000 | +17.3% | 23,844 | +1.8% | 0.00% | – |
Q2 2021 | $405,000 | -24.2% | 23,428 | -12.9% | 0.00% | – |
Q1 2021 | $534,000 | +11.0% | 26,907 | -2.4% | 0.00% | – |
Q4 2020 | $481,000 | +28.6% | 27,570 | +41.9% | 0.00% | – |
Q3 2020 | $374,000 | -3.9% | 19,428 | -2.9% | 0.00% | – |
Q2 2020 | $389,000 | +62.1% | 20,003 | +16.8% | 0.00% | – |
Q1 2020 | $240,000 | -14.9% | 17,128 | +48.8% | 0.00% | – |
Q4 2019 | $282,000 | – | 11,508 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 1,621,118 | $38,939,254 | 45.05% |
NEA Management Company, LLC | 4,186,243 | $100,553,557 | 6.95% |
Frazier Life Sciences Management, L.P. | 3,860,107 | $92,719,770 | 6.71% |
Prosight Management, LP | 567,826 | $13,639,181 | 6.47% |
TANG CAPITAL MANAGEMENT LLC | 1,170,000 | $28,103,400 | 4.19% |
Highlander Partners, L.P. | 122,980 | $2,953,980 | 4.00% |
Novo Holdings A/S | 1,684,193 | $40,454,316 | 2.67% |
CADIAN CAPITAL MANAGEMENT, LP | 734,922 | $17,652,826 | 1.10% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,032,335 | $48,816,687 | 1.09% |
SILVERARC CAPITAL MANAGEMENT, LLC | 105,939 | $2,544,655 | 1.05% |